Carrie B. Wiese

1.2k citations
20 papers · 856 indexed · h-index 13

Carrie B. Wiese

19 papers receiving 849 citations

Peers

Carrie B. Wiese
Comparison fields: 5 of 91
  • Cancer Research 307
  • Urology 70
  • Molecular Biology 453
  • Immunology 124
  • Endocrinology, Diabetes and Metabolism 65
Replace Roberto Bandiera with:
Roberto Bandiera United Kingdom
Dechao Feng China
Qiang Feng China
Sabrina Ben Larbi France
Jianguo Shi China
Yukiko Kitase United States
Zhengming Wang China
Michel Fausther United States
Kenji Kitajima Japan
Carrie B. Wiese relative to Roberto Bandiera United Kingdom Roberto Bandiera's profile →
Citations per field
00.5×3.3×
Roberto Bandiera · 1×
Citations per year

Countries citing papers authored by Carrie B. Wiese

Since Specialization
Citations

This map shows the geographic impact of Carrie B. Wiese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie B. Wiese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie B. Wiese more than expected).

Fields of papers citing papers by Carrie B. Wiese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie B. Wiese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie B. Wiese. The network helps show where Carrie B. Wiese may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carrie B. Wiese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carrie B. Wiese Line = papers co-authored together Carrie B. Wiese links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20240
3 20244
4 202318
5 202267
6 202214
7 202118
8 202069
9 201924
10 201947
11 201720
12 20171
13 201651
14 2015105
15 2014335
16 201459
17 20141
18 201214
19 20125
20 20122

About Carrie B. Wiese

Carrie B. Wiese is a scholar working on Complementary and Manual Therapy, Urology and Cancer Research, having authored 20 papers that have together received 856 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Congenital gastrointestinal and neural anomalies (4 papers), Cancer-related molecular mechanisms research (4 papers), Epigenetics and DNA Methylation (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers), Cardiovascular Disease and Adiposity (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Urological Disorders and Treatments (2 papers). The work is most often cited by research in Cancer Research (307 citations), Urology (70 citations) and Molecular Biology (453 citations). Carrie B. Wiese has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Karen Reue, Kasey C. Vickers, Luisa Torres, Fatiha Tabet, Alan T. Remaley, Gilles Lambert, Leonel Prado-Lourenço, Kerry-Anne Rye, Seth G. Thacker and Michael G. Levin. Their work appears in journals such as Advanced Materials, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026